Pascal E. R. Girin - 19 May 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Director
Issuer ticker: CLPT
Reported as of: 19 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 May 2026, 16:30:07 UTC
Prior SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Danilo D'Alessandro, by Power of Attorney for Pascal E. R. Girin

Key filing fact

Pascal E. R. Girin filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 21 May 2026.

Key facts

This page summarizes Pascal E. R. Girin's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 May 2026, 16:30.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001329811 Primary reporting owner

Girin Pascal E R

Relationship: Director
Address: C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature: /s/ Danilo D'Alessandro, by Power of Attorney for Pascal E. R. Girin
Signature date: 21 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,417
Change %: +13%
Price
Shares after: 110,623
Date: 19 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -12,417
Change %: -100%
Price
Shares after: 0
Date: 19 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,417
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Pascal E. R. Girin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.